Abcam’s aim is to serve life science researchers to achieve their mission, faster. We continuously listen, collaborate and support the scientific community in order to improve and offer new affinity binders, reagents, biomarkers and assays that will drive greater scientific progress. Our culture is a key differentiator. We believe in empowering individuals, with responsibility given at an early stage. The working environment is fun and fast-paced, collaborative and outcome focused, with a strong customer focus. In addition to competitive salaries we offer an attractive flexible benefits package with plenty of opportunities to learn and grow. Our head office is in Cambridge (UK), we also have offices in Bristol (UK), Cambridge, Eugene and San Francisco (USA), Tokyo (Japan), Hong Kong, Hangzhou and Shanghai (China). We have a range of roles in IT background and would normally look for candidates with a degree in computer science or other numerate disciplines. We also recruit positions for candidates with a scientific background and we would normally look for candidates with biological science qualifications.
Show more
Type
Public
HQ
Milton, GB
Founded
1998
Size (employees)
948 (est)+8%
Website
abcam.com
Abcam was founded in 1998 and is headquartered in Milton, GB
Report incorrect company information

Key People/Management at Abcam

Jonathan Milner

Jonathan Milner

CEO

Abcam Office Locations

Abcam has offices in San Francisco, Eugene, Tokyo, Milton and in 8 other locations
Milton, GB (HQ)
330 Cambridge Science Park Milton Rd
Cambridge, US (HQ)
b2304 One Kendall Square Binney St
Shanghai, CN
Galileo Rd. Pudong
Tokyo, JP
2-2-1 Nihonbashi Horidome-cho
Cambridge, US
b2304 1 Kendall Square
Show all (13)
Report incorrect company information

Abcam Financials and Metrics

Abcam Revenue

Embed Graph
Abcam's revenue was reported to be £217.10 m in FY, 2017
GBP

Revenue (FY, 2017)

217.1 m

Gross profit (FY, 2017)

152.1 m

Gross profit margin (FY, 2017), %

70.1%

Net income (FY, 2017)

42.4 m

EBITDA (FY, 2017)

70.5 m

EBIT (FY, 2017)

55.1 m

Cash (30-Jun-2017)

84.8 m
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

248.4 k719.6 k1.8 m3.5 m6.7 m12.1 m19.4 m24.5 m36.7 m56.8 m71.1 m83.3 m97.8 m122.2 m128 m144 m171.7 m217.1 m

Revenue growth, %

13%19%

Cost of goods sold

160.4 k416.1 k820.6 k1.4 m2.5 m4.7 m7.5 m10 m14.4 m19.4 m23.7 m27.2 m30.3 m35.5 m37.6 m42.5 m51.1 m65 m

Gross profit

88 k303.5 k983.7 k2.1 m4.2 m7.5 m11.9 m14.5 m22.3 m37.4 m47.4 m56 m67.6 m86.7 m90.4 m101.5 m120.5 m152.1 m
GBPFY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

9.6 k269.1 k87.3 k59.1 k66.1 k274.3 k510 k884 k2.2 m13.5 m25.5 m40.2 m55.6 m14 m37.3 m55.3 m57.1 m68.9 m84.8 m

Accounts Receivable

55.1 k158.6 k261 k424.8 k926.8 k1.7 m2.4 m3.3 m3.7 m5.4 m6.8 m7.9 m11.5 m12.1 m13.2 m19.6 m

Inventories

3.2 k4 k18.1 k69.4 k185.9 k557.8 k1.2 m2.4 m3.1 m4.5 m6.8 m9.1 m10.7 m15.4 m15.3 m14.8 m19.8 m19.7 m21.8 m

Current Assets

33.6 k362.3 k320.8 k696.5 k864.3 k2.7 m4.6 m17 m18.1 m23.9 m40.1 m58.5 m76.4 m48.7 m71.3 m90.9 m100.5 m119.7 m143.5 m
GBPFY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(190.1 k)(471.9 k)(328.2 k)517.2 k1 m2.3 m3.7 m4.1 m5.9 m12.3 m19.2 m23.8 m25.4 m32.7 m34 m37.4 m37.4 m42.4 m

Cash From Operating Activities

2.6 m3.5 m4.9 m7.1 m14.8 m19.7 m25.5 m24.5 m39.4 m41.3 m40.2 m47.3 m66.4 m

Dividends Paid

300 k1.3 m1.2 m968 k2.6 m5.3 m7.9 m10.1 m12.5 m11.3 m15.9 m16.7 m19.1 m

Cash From Financing Activities

570 k9.3 m47 k(2.2 m)(1.2 m)(27.4 m)(7.6 m)10.7 m(11.8 m)(13.8 m)(14.1 m)(15.4 m)(17.7 m)
GBPY, 2017

Revenue/Employee

237.3 k

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Abcam Online and Social Media Presence

Embed Graph
Report incorrect company information

Abcam News and Updates

Alpha-lactalbumin Market : Industry Perspective and Comprehensive Analysis 2024

Persistence Market Research has announced the addition of the “Alpha-lactalbumin Market: Global Industry Analysis and Opportunity Assessment 2016 - 2024" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Future of Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market including key players Abcam, BD, bioMerieux, Bio-Rad Laboratories

Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Posted via Industry Today. Follow us on Twitter @IndustryToday

Antibodies Global Market 2018: Key Players – Abcam PLC, Abnova, Active Motif, Agilent Technologies, BD Biosciences, Beckman Coulter Inc.

Antibodies -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

UPDATE 1-Brazil truckers association Abcam recommends end of strike

SAO PAULO, May 28 (Reuters) - A Brazilian truckers association behind a week-long nationwide fuel-price protest that paralyzed key sectors of Latin America's biggest economy told drivers to get back to work on Monday after the government caved in to their demands.

Protein Assays Market 10.8% of CAGR Expected by 2023 with Abcam plc, Lucigen Co, QIAGEN, Illumina Inc, Takara Bio Inc

Protein Assays Market Research Report– by Type (Copper-Ion-Based Assays, Test Strip-Based Assays, and Dye-Binding Assays), By Application (Diagnosis, Drug Discovery, and Protein Purification), By Product, By Technology, and By End User– Global forecast till 2023 Posted via Industry Today. Follow us …

Monoclonal Antibody Custom Service Market Accruals of Tremendous Growth by 2023 At 10.84% of CAGR

Monoclonal Antibody Custom Service Market provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

Abcam Company Life and Culture

Report incorrect company information